21 results on '"Landefeld, S"'
Search Results
2. Physicians' and Family Members' Perception of a Family Support Intervention in Intensive Care Units
- Author
-
Lincoln, T.E., primary, Shields, A.-M., additional, Petty, K., additional, Campbell, T., additional, Bellon, J., additional, Buddadhumaruk, P., additional, Seaman, J.B., additional, Rak, K., additional, Pidro, C., additional, Gustafson, R.M., additional, Kahn, J.M., additional, Happ, M.B., additional, Song, M.-K., additional, Reynolds, III, C.F., additional, Morse, J., additional, Landefeld, S., additional, Angus, D.C., additional, Arnold, R.M., additional, and White, D.B., additional
- Published
- 2020
- Full Text
- View/download PDF
3. Multicenter Randomized Trial of the Four Supports Intervention for Surrogate Decision Makers in ICUs
- Author
-
White, D.B., primary, Arnold, R.M., additional, Seaman, J.B., additional, Buddadhumaruk, P., additional, Shields, A.-M., additional, Gustafon, R.M., additional, Felman, K., additional, Nedwick, W., additional, SanPedro, R., additional, Mackenzie, S., additional, Pidro, C., additional, Morse, J.Q., additional, Chang, C.-C.H., additional, Happ, M.B., additional, Song, M.-K., additional, Kahn, J.M., additional, Landefeld, S., additional, Reynolds, C.F., additional, and Angus, D.C., additional
- Published
- 2020
- Full Text
- View/download PDF
4. Screening for Osteoporosis to Prevent Fractures: US Preventive Services Task Force Recommendation Statement
- Author
-
Curry, SJ, Krist, AH, Owens, DK, Barry, MJ, Caughey, AB, Davidson, KW, Doubeni, CA, Jr, EJW, Kemper, AR, Kubik, M, Landefeld, S, Mangione, CM, Phipps, MG, Pignone, M, Silverstein, M, Simon, MA, Tseng, C-W, Wong, JB, and Force, USPST
- Subjects
Male ,Diphosphonates ,Bone Density Conservation Agents ,Middle Aged ,Photon ,Medical and Health Sciences ,US Preventive Services Task Force ,Postmenopause ,General & Internal Medicine ,Humans ,Osteoporosis ,Mass Screening ,Female ,Absorptiometry ,Osteoporotic Fractures ,Aged - Abstract
ImportanceBy 2020, approximately 12.3 million individuals in the United States older than 50 years are expected to have osteoporosis. Osteoporotic fractures, particularly hip fractures, are associated with limitations in ambulation, chronic pain and disability, loss of independence, and decreased quality of life, and 21% to 30% of patients who experience a hip fracture die within 1 year. The prevalence of primary osteoporosis (ie, osteoporosis without underlying disease) increases with age and differs by race/ethnicity. With the aging of the US population, the potential preventable burden is likely to increase in future years.ObjectiveTo update the 2011 US Preventive Services Task Force (USPSTF) recommendation on screening for osteoporosis.Evidence reviewThe USPSTF reviewed the evidence on screening for and treatment of osteoporotic fractures in men and women, as well as risk assessment tools, screening intervals, and efficacy of screening and treatment in subgroups. The screening population was postmenopausal women and older men with no known previous osteoporotic fractures and no known comorbid conditions or medication use associated with secondary osteoporosis.FindingsThe USPSTF found convincing evidence that bone measurement tests are accurate for detecting osteoporosis and predicting osteoporotic fractures in women and men. The USPSTF found adequate evidence that clinical risk assessment tools are moderately accurate in identifying risk of osteoporosis and osteoporotic fractures. The USPSTF found convincing evidence that drug therapies reduce subsequent fracture rates in postmenopausal women. The USPSTF found that the evidence is inadequate to assess the effectiveness of drug therapies in reducing subsequent fracture rates in men without previous fractures.Conclusions and recommendationThe USPSTF recommends screening for osteoporosis with bone measurement testing to prevent osteoporotic fractures in women 65 years and older. (B recommendation) The USPSTF recommends screening for osteoporosis with bone measurement testing to prevent osteoporotic fractures in postmenopausal women younger than 65 years at increased risk of osteoporosis, as determined by a formal clinical risk assessment tool. (B recommendation) The USPSTF concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening for osteoporosis to prevent osteoporotic fractures in men. (I statement).
- Published
- 2018
5. Vitamin D, Calcium, or Combined Supplementation for the Primary Prevention of Fractures in Community-Dwelling Adults: US Preventive Services Task Force Recommendation Statement
- Author
-
Grossman, DC, Curry, SJ, Owens, DK, Barry, MJ, Caughey, AB, Davidson, KW, Doubeni, CA, Jr, EJW, Kemper, AR, Krist, AH, Kubik, M, Landefeld, S, Mangione, CM, Silverstein, M, Simon, MA, Tseng, C-W, and Force, USPST
- Subjects
Adult ,Male ,Aging ,Medical and Health Sciences ,US Preventive Services Task Force ,Drug Therapy ,Clinical Research ,General & Internal Medicine ,Complementary and Integrative Health ,Humans ,Vitamin D ,3.3 Nutrition and chemoprevention ,Bone ,Nutrition ,Prevention ,Vitamins ,Primary Prevention ,Postmenopause ,6.1 Pharmaceuticals ,Musculoskeletal ,Combination ,Dietary Supplements ,Osteoporosis ,Calcium ,Female ,Independent Living ,Fractures ,Osteoporotic Fractures - Abstract
Importance:Because of the aging population, osteoporotic fractures are an increasingly important cause of morbidity and mortality in the United States. Approximately 2 million osteoporotic fractures occurred in the United States in 2005, and annual incidence is projected to increase to more than 3 million fractures by 2025. Within 1 year of experiencing a hip fracture, many patients are unable to walk independently, more than half require assistance with activities of daily living, and 20% to 30% of patients will die. Objective:To update the 2013 US Preventive Services Task Force (USPSTF) recommendation on vitamin D supplementation, with or without calcium, to prevent fractures. Evidence Review:The USPSTF reviewed the evidence on vitamin D, calcium, and combined supplementation for the primary prevention of fractures in community-dwelling adults (defined as not living in a nursing home or other institutional care setting). The review excluded studies conducted in populations with a known disorder related to bone metabolism (eg, osteoporosis or vitamin D deficiency), taking medications known to be associated with osteoporosis (eg, long-term steroids), or with a previous fracture. Findings:The USPSTF found inadequate evidence to estimate the benefits of vitamin D, calcium, or combined supplementation to prevent fractures in community-dwelling men and premenopausal women. The USPSTF found adequate evidence that daily supplementation with 400 IU or less of vitamin D and 1000 mg or less of calcium has no benefit for the primary prevention of fractures in community-dwelling, postmenopausal women. The USPSTF found inadequate evidence to estimate the benefits of doses greater than 400 IU of vitamin D or greater than 1000 mg of calcium to prevent fractures in community-dwelling postmenopausal women. The USPSTF found adequate evidence that supplementation with vitamin D and calcium increases the incidence of kidney stones. Conclusions and Recommendation:The USPSTF concludes that the current evidence is insufficient to assess the balance of the benefits and harms of vitamin D and calcium supplementation, alone or combined, for the primary prevention of fractures in community-dwelling, asymptomatic men and premenopausal women. (I statement) The USPSTF concludes that the current evidence is insufficient to assess the balance of the benefits and harms of daily supplementation with doses greater than 400 IU of vitamin D and greater than 1000 mg of calcium for the primary prevention of fractures in community-dwelling, postmenopausal women. (I statement) The USPSTF recommends against daily supplementation with 400 IU or less of vitamin D and 1000 mg or less of calcium for the primary prevention of fractures in community-dwelling, postmenopausal women. (D recommendation) These recommendations do not apply to persons with a history of osteoporotic fractures, increased risk for falls, or a diagnosis of osteoporosis or vitamin D deficiency.
- Published
- 2018
6. Screening for Latent Tuberculosis Infection in Adults: US Preventive Services Task Force Recommendation Statement
- Author
-
Bibbins-Domingo, K, Grossman, DC, Curry, SJ, Bauman, L, Davidson, KW, Jr, EJW, Garcia, FAR, Herzstein, J, Kemper, AR, Krist, AH, Kurth, AE, Landefeld, S, Mangione, CM, Phillips, WR, Phipps, MG, Pignone, MP, and Force, USPST
- Subjects
Adult ,Primary Health Care ,Prevention ,Advisory Committees ,Health Services ,bacterial infections and mycoses ,Risk Assessment ,Medical and Health Sciences ,US Preventive Services Task Force ,Infectious Diseases ,Rare Diseases ,Good Health and Well Being ,Clinical Research ,Latent Tuberculosis ,General & Internal Medicine ,Humans ,Tuberculosis ,Mass Screening ,Infection - Abstract
ImportanceTuberculosis remains an important preventable disease in the United States. An effective strategy for reducing the transmission, morbidity, and mortality of active disease is the identification and treatment of latent tuberculosis infection (LTBI) to prevent progression to active disease.ObjectiveTo issue a current US Preventive Services Task Force (USPSTF) recommendation on screening for LTBI.Evidence reviewThe USPSTF reviewed the evidence on screening for LTBI in asymptomatic adults seen in primary care, including evidence dating from the inception of searched databases.FindingsThe USPSTF found adequate evidence that accurate screening tests for LTBI are available, treatment of LTBI provides a moderate health benefit in preventing progression to active disease, and the harms of screening and treatment are small. The USPSTF has moderate certainty that screening for LTBI in persons at increased risk for infection provides a moderate net benefit.Conclusions and recommendationThe USPSTF recommends screening for LTBI in populations at increased risk. (B recommendation).
- Published
- 2016
7. Hemorrhagic complications of anticoagulant treatment
- Author
-
Levine, M. N., primary, Hirsh, J., additional, Landefeld, S., additional, and Raskob, G., additional
- Published
- 1992
- Full Text
- View/download PDF
8. Faculty development for the 21st century: lessons from the Society of General Internal Medicine-Hartford Collaborative Centers for the Care of Older Adults.
- Author
-
Williams BC, Weber V, Babbott SF, Kirk LM, Heflin MT, O'Toole E, Schapira MM, Eckstrom E, Tulsky A, Wolf AM, and Landefeld S
- Abstract
In this review of a recent set of faculty development initiatives to promote geriatrics teaching by general internists, nontraditional strategies to promote sustained change were identified, included enrolling a limited number of 'star' faculty, creating ongoing working relationships between faculty, and developing projects for clinical or education program improvement. External funding, although limited, garnered administration support and was associated with changes in individual career trajectories. Activities to enfranchise top leadership were felt essential to sustain change. Traditional faculty development programs for clinician educators are periodic, seminar-based interventions to enhance teaching and clinical skills. In 2003/04 the Collaborative Centers for Research and Education in the Care of Older Adults were funded by the John A. Hartford Foundation and administered by the Society of General Internal Medicine. Ten academic medical centers received individual grants of $91,000, with required cost sharing, to develop collaborations between general internists and geriatricians to create sustained change in geriatrics clinical teaching and learning. Through written and structured telephone surveys, activities designed to foster sustainability at funded sites were identified, and the activities and perceived effects of funding at the 10 funded sites were compared with those of the 11 highest-ranking unfunded sites. The experience of the Collaborative Centers supports the conclusion that modest, targeted funding can provide the credibility and legitimacy crucial for clinician educators to allocate time and energy in new directions. Key success factors likely include high intensity and duration, integration into career trajectories, integration into clinical programs, and activities to enfranchise institutional leadership. [ABSTRACT FROM AUTHOR]
- Published
- 2007
- Full Text
- View/download PDF
9. Hemorrhagic complications of anticoagulant treatment.
- Author
-
Levine, Mark N., Raskob, Gary, Landefeld, Seth, Levine, M N, Raskob, G, Landefeld, S, and Kearon, C
- Subjects
HEMORRHAGE ,ANTICOAGULANTS - Abstract
Bleeding is the major complication of anticoagulant therapy. The criteria for defining the severity of bleeding varied considerably between studies, accounting in part for the variation in the rates of bleeding reported. Since the last review, there have been several meta-analyses published on the rates of major bleeding in trials of anticoagulants for atrial fibrillation and ischemic heart disease. The major determinants of oral anticoagulant-induced bleeding are the intensity of the anticoagulant effect, underlying patient characteristics, and the length of therapy. There is good evidence that low-intensity oral anticoagulant therapy (targeted INR of 2.5; range, 2.0 to 3.0) is associated with a lower risk of bleeding than therapy targeted at a higher intensity. Lower-intensity regimens (INR < 2.0) are associated with an even smaller increase in major bleeding. In terms of treatment decision making for anticoagulant therapy, bleeding risk cannot be considered alone, ie, the potential decrease in thromboembolism must be balanced against the potential increased bleeding risk. The risk of bleeding associated with IV heparin in patients with acute venous thromboembolism is < 3% in recent trials. There is some evidence to suggest that this bleeding risk increases with the heparin dosage and age (> 70 years). LMW heparin is not associated with increased major bleeding compared with standard heparin in acute venous thromboembolism. Standard heparin and LMW heparin are not associated with an increase in major bleeding in ischemic coronary syndromes, but are associated with an increase in major bleeding in ischemic stroke. [ABSTRACT FROM AUTHOR]
- Published
- 2001
- Full Text
- View/download PDF
10. Behavioral Counseling Interventions to Promote a Healthy Diet and Physical Activity for Cardiovascular Disease Prevention in Adults With Cardiovascular Risk Factors: US Preventive Services Task Force Recommendation Statement.
- Author
-
Krist AH, Davidson KW, Mangione CM, Barry MJ, Cabana M, Caughey AB, Donahue K, Doubeni CA, Epling JW Jr, Kubik M, Landefeld S, Ogedegbe G, Pbert L, Silverstein M, Simon MA, Tseng CW, and Wong JB
- Subjects
- Adult, Dyslipidemias, Heart Disease Risk Factors, Humans, Hypertension, Cardiovascular Diseases prevention & control, Counseling, Diet, Healthy, Exercise, Health Behavior
- Abstract
Importance: Cardiovascular disease (CVD) is a leading cause of death in the US. Known modifiable risk factors for CVD include smoking, overweight and obesity, diabetes, elevated blood pressure or hypertension, dyslipidemia, lack of physical activity, and unhealthy diet. Adults who adhere to national guidelines for a healthy diet and physical activity have lower cardiovascular morbidity and mortality than those who do not. All persons, regardless of their CVD risk status, benefit from healthy eating behaviors and appropriate physical activity., Objective: To update its 2014 recommendation, the USPSTF commissioned a review of the evidence on behavioral counseling to promote a healthy diet and physical activity for CVD prevention in adults with cardiovascular risk factors., Population: This recommendation statement applies to adults 18 years or older with known hypertension or elevated blood pressure, those with dyslipidemia, or those who have mixed or multiple risk factors such as metabolic syndrome or an estimated 10-year CVD risk of 7.5% or greater. Adults with other known modifiable cardiovascular risk factors such as abnormal blood glucose levels, obesity, and smoking are not included in this recommendation., Evidence Assessment: The USPSTF concludes with moderate certainty that behavioral counseling interventions have a moderate net benefit on CVD risk in adults at increased risk for CVD., Recommendation: The USPSTF recommends offering or referring adults with CVD risk factors to behavioral counseling interventions to promote a healthy diet and physical activity. (B recommendation).
- Published
- 2020
- Full Text
- View/download PDF
11. Protocol and Fidelity Monitoring Plan for Four Supports. A Multicenter Trial of an Intervention to Support Surrogate Decision Makers in Intensive Care Units.
- Author
-
Seaman JB, Arnold RM, Buddadhumaruk P, Shields AM, Gustafson RM, Felman K, Newdick W, SanPedro R, Mackenzie S, Morse JQ, Chang CH, Happ MB, Song MK, Kahn JM, Reynolds CF 3rd, Angus DC, Landefeld S, and White DB
- Subjects
- Humans, Grief, Hospital Costs, Length of Stay statistics & numerical data, Outcome and Process Assessment, Health Care, Professional-Family Relations, Randomized Controlled Trials as Topic, Multicenter Studies as Topic, Anxiety psychology, Communication, Critical Illness economics, Critical Illness therapy, Decision Making, Depression psychology, Family psychology, Intensive Care Units, Proxy psychology, Social Support
- Abstract
Individuals acting as surrogate decision makers for critically ill patients frequently struggle in this role and experience high levels of long-term psychological distress. Prior interventions designed to improve the sharing of information by the clinical team with surrogate decision makers have demonstrated little effect on surrogates' outcomes or clinical decisions. In this report, we describe the study protocol and corresponding intervention fidelity monitoring plan for a multicenter randomized clinical trial testing the impact of a multifaceted surrogate support intervention (Four Supports) on surrogates' psychological distress, the quality of decisions about goals of care, and healthcare use. We will randomize the surrogates of 300 incapacitated critically ill patients at high risk of death and/or severe long-term functional impairment to receive the Four Supports intervention or an education control. The Four Supports intervention adds to the intensive care unit (ICU) team a trained interventionist (family support specialist) who delivers four types of protocolized support-emotional support; communication support; decisional support; and, if indicated, anticipatory grief support-to surrogates through daily interactions during the ICU stay. The primary outcome is surrogates' symptoms of anxiety and depression at 6-month follow-up, measured with the Hospital Anxiety and Depression Scale. Prespecified secondary outcome measures are the Patient Perception of Patient Centeredness Scale (modified for use with surrogates) and Impact of Event Scale scores at 3- and 6-month follow-up, respectively, together with ICU and hospital lengths of stay and total hospital cost among decedents. The fidelity monitoring plan entails establishing and measuring adherence to the intervention using multiple measurement methods, including daily checklists and coding of audiorecorded encounters. This approach to intervention fidelity may benefit others designing and testing behavioral interventions in the ICU setting. Clinical trial registered with www.clinicaltrials.gov (NCT01982877).
- Published
- 2018
- Full Text
- View/download PDF
12. Interventions to Prevent Falls in Community-Dwelling Older Adults: US Preventive Services Task Force Recommendation Statement.
- Author
-
Grossman DC, Curry SJ, Owens DK, Barry MJ, Caughey AB, Davidson KW, Doubeni CA, Epling JW Jr, Kemper AR, Krist AH, Kubik M, Landefeld S, Mangione CM, Pignone M, Silverstein M, Simon MA, and Tseng CW
- Subjects
- Aged, Bone Density Conservation Agents adverse effects, Bone Density Conservation Agents therapeutic use, Dietary Supplements, Humans, Independent Living, Vitamin D adverse effects, Vitamin D therapeutic use, Accidental Falls prevention & control, Exercise Therapy adverse effects
- Abstract
Importance: Falls are the leading cause of injury-related morbidity and mortality among older adults in the United States. In 2014, 28.7% of community-dwelling adults 65 years or older reported falling, resulting in 29 million falls (37.5% of which needed medical treatment or restricted activity for a day or longer) and an estimated 33 000 deaths in 2015., Objective: To update the 2012 US Preventive Services Task Force (USPSTF) recommendation on the prevention of falls in community-dwelling older adults., Evidence Review: The USPSTF reviewed the evidence on the effectiveness and harms of primary care-relevant interventions to prevent falls and fall-related morbidity and mortality in community-dwelling older adults 65 years or older who are not known to have osteoporosis or vitamin D deficiency., Findings: The USPSTF found adequate evidence that exercise interventions have a moderate benefit in preventing falls in older adults at increased risk for falls and that multifactorial interventions have a small benefit. The USPSTF found adequate evidence that vitamin D supplementation has no benefit in preventing falls in older adults. The USPSTF found adequate evidence to bound the harms of exercise and multifactorial interventions as no greater than small. The USPSTF found adequate evidence that the overall harms of vitamin D supplementation are small to moderate., Conclusions and Recommendation: The USPSTF recommends exercise interventions to prevent falls in community-dwelling adults 65 years or older who are at increased risk for falls. (B recommendation) The USPSTF recommends that clinicians selectively offer multifactorial interventions to prevent falls in community-dwelling adults 65 years or older who are at increased risk for falls. Existing evidence indicates that the overall net benefit of routinely offering multifactorial interventions to prevent falls is small. When determining whether this service is appropriate for an individual, patients and clinicians should consider the balance of benefits and harms based on the circumstances of prior falls, presence of comorbid medical conditions, and the patient's values and preferences. (C recommendation) The USPSTF recommends against vitamin D supplementation to prevent falls in community-dwelling adults 65 years or older. (D recommendation) These recommendations apply to community-dwelling adults who are not known to have osteoporosis or vitamin D deficiency.
- Published
- 2018
- Full Text
- View/download PDF
13. Vitamin D, Calcium, or Combined Supplementation for the Primary Prevention of Fractures in Community-Dwelling Adults: US Preventive Services Task Force Recommendation Statement.
- Author
-
Grossman DC, Curry SJ, Owens DK, Barry MJ, Caughey AB, Davidson KW, Doubeni CA, Epling JW Jr, Kemper AR, Krist AH, Kubik M, Landefeld S, Mangione CM, Silverstein M, Simon MA, and Tseng CW
- Subjects
- Adult, Calcium adverse effects, Drug Therapy, Combination, Female, Humans, Independent Living, Male, Osteoporotic Fractures prevention & control, Postmenopause, Primary Prevention, Vitamin D adverse effects, Vitamins adverse effects, Calcium therapeutic use, Dietary Supplements, Fractures, Bone prevention & control, Vitamin D therapeutic use, Vitamins therapeutic use
- Abstract
Importance: Because of the aging population, osteoporotic fractures are an increasingly important cause of morbidity and mortality in the United States. Approximately 2 million osteoporotic fractures occurred in the United States in 2005, and annual incidence is projected to increase to more than 3 million fractures by 2025. Within 1 year of experiencing a hip fracture, many patients are unable to walk independently, more than half require assistance with activities of daily living, and 20% to 30% of patients will die., Objective: To update the 2013 US Preventive Services Task Force (USPSTF) recommendation on vitamin D supplementation, with or without calcium, to prevent fractures., Evidence Review: The USPSTF reviewed the evidence on vitamin D, calcium, and combined supplementation for the primary prevention of fractures in community-dwelling adults (defined as not living in a nursing home or other institutional care setting). The review excluded studies conducted in populations with a known disorder related to bone metabolism (eg, osteoporosis or vitamin D deficiency), taking medications known to be associated with osteoporosis (eg, long-term steroids), or with a previous fracture., Findings: The USPSTF found inadequate evidence to estimate the benefits of vitamin D, calcium, or combined supplementation to prevent fractures in community-dwelling men and premenopausal women. The USPSTF found adequate evidence that daily supplementation with 400 IU or less of vitamin D and 1000 mg or less of calcium has no benefit for the primary prevention of fractures in community-dwelling, postmenopausal women. The USPSTF found inadequate evidence to estimate the benefits of doses greater than 400 IU of vitamin D or greater than 1000 mg of calcium to prevent fractures in community-dwelling postmenopausal women. The USPSTF found adequate evidence that supplementation with vitamin D and calcium increases the incidence of kidney stones., Conclusions and Recommendation: The USPSTF concludes that the current evidence is insufficient to assess the balance of the benefits and harms of vitamin D and calcium supplementation, alone or combined, for the primary prevention of fractures in community-dwelling, asymptomatic men and premenopausal women. (I statement) The USPSTF concludes that the current evidence is insufficient to assess the balance of the benefits and harms of daily supplementation with doses greater than 400 IU of vitamin D and greater than 1000 mg of calcium for the primary prevention of fractures in community-dwelling, postmenopausal women. (I statement) The USPSTF recommends against daily supplementation with 400 IU or less of vitamin D and 1000 mg or less of calcium for the primary prevention of fractures in community-dwelling, postmenopausal women. (D recommendation) These recommendations do not apply to persons with a history of osteoporotic fractures, increased risk for falls, or a diagnosis of osteoporosis or vitamin D deficiency.
- Published
- 2018
- Full Text
- View/download PDF
14. Behavioral Counseling to Prevent Skin Cancer: US Preventive Services Task Force Recommendation Statement.
- Author
-
Grossman DC, Curry SJ, Owens DK, Barry MJ, Caughey AB, Davidson KW, Doubeni CA, Epling JW Jr, Kemper AR, Krist AH, Kubik M, Landefeld S, Mangione CM, Silverstein M, Simon MA, and Tseng CW
- Subjects
- Adolescent, Adult, Child, Child, Preschool, Humans, Infant, Precancerous Conditions prevention & control, Self-Examination, Skin Pigmentation, Sunscreening Agents adverse effects, Young Adult, Counseling methods, Health Behavior, Skin Neoplasms prevention & control, Sunburn prevention & control
- Abstract
Importance: Skin cancer is the most common type of cancer in the United States. Although invasive melanoma accounts for only 2% of all skin cancer cases, it is responsible for 80% of skin cancer deaths. Basal and squamous cell carcinoma, the 2 predominant types of nonmelanoma skin cancer, represent the vast majority of skin cancer cases., Objective: To update the 2012 US Preventive Services Task Force (USPSTF) recommendation on behavioral counseling for the primary prevention of skin cancer and the 2009 recommendation on screening for skin cancer with skin self-examination., Evidence Review: The USPSTF reviewed the evidence on whether counseling patients about sun protection reduces intermediate outcomes (eg, sunburn or precursor skin lesions) or skin cancer; the link between counseling and behavior change, the link between behavior change and skin cancer incidence, and the harms of counseling or changes in sun protection behavior; and the link between counseling patients to perform skin self-examination and skin cancer outcomes, as well as the harms of skin self-examination., Findings: The USPSTF determined that behavioral counseling interventions are of moderate benefit in increasing sun protection behaviors in children, adolescents, and young adults with fair skin types. The USPSTF found adequate evidence that behavioral counseling interventions result in a small increase in sun protection behaviors in adults older than 24 years with fair skin types. The USPSTF found inadequate evidence on the benefits and harms of counseling adults about skin self-examination to prevent skin cancer., Conclusions and Recommendation: The USPSTF recommends counseling young adults, adolescents, children, and parents of young children about minimizing exposure to UV radiation for persons aged 6 months to 24 years with fair skin types to reduce their risk of skin cancer. (B recommendation) The USPSTF recommends that clinicians selectively offer counseling to adults older than 24 years with fair skin types about minimizing their exposure to UV radiation to reduce risk of skin cancer. Existing evidence indicates that the net benefit of counseling all adults older than 24 years is small. In determining whether this service is appropriate in individual cases, patients and clinicians should consider the presence of risk factors for skin cancer. (C recommendation) The USPSTF concludes that the current evidence is insufficient to assess the balance of benefits and harms of counseling adults about skin self-examination to prevent skin cancer. (I statement).
- Published
- 2018
- Full Text
- View/download PDF
15. Electrochemical patterning and detection of DNA arrays on a two-electrode platform.
- Author
-
Furst A, Landefeld S, Hill MG, and Barton JK
- Subjects
- Catalysis, Copper chemistry, Hybridization, Genetic, DNA chemistry, Electrochemistry instrumentation, Electrodes, Oligonucleotide Array Sequence Analysis instrumentation
- Abstract
We report a novel method of DNA array formation that is electrochemically formed and addressed with a two-electrode platform. Electrochemical activation of a copper catalyst, patterned with one electrode, enables precise placement of multiple sequences of DNA onto a second electrode surface. The two-electrode patterning and detection platform allows for both spatial resolution of the patterned DNA array and optimization of detection through DNA-mediated charge transport with electrocatalysis. This two-electrode platform has been used to form arrays that enable differentiation between well-matched and mismatched sequences, the detection of TATA-binding protein, and sequence-selective DNA hybridization.
- Published
- 2013
- Full Text
- View/download PDF
16. Electrochemistry of mammalian cytochrome P450 2B4 indicates tunable thermodynamic parameters in surfactant films.
- Author
-
Hagen KD, Gillan JM, Im SC, Landefeld S, Mead G, Hiley M, Waskell LA, Hill MG, and Udit AK
- Subjects
- Animals, Cytochrome P450 Family 2, Electrochemical Techniques, Humans, Oxidation-Reduction, Silicon Dioxide chemistry, Thermodynamics, Aryl Hydrocarbon Hydroxylases chemistry, Heme chemistry, Membranes, Artificial, Quaternary Ammonium Compounds chemistry
- Abstract
Electrochemical methods continue to present an attractive means for achieving in vitro biocatalysis with cytochromes P450; however understanding fully the nature of electrode-bound P450 remains elusive. Herein we report thermodynamic parameters using electrochemical analysis of full-length mammalian microsomal cytochrome P450 2B4 (CYP 2B4) in didodecyldimethylammonium bromide (DDAB) surfactant films. Electronic absorption spectra of CYP 2B4-DDAB films on silica slides reveal an absorption maximum at 418nm, characteristic of low-spin, six-coordinate, water-ligated Fe(III) heme in P450. The Fe(III/II) and Fe(II/I) redox couples (E1/2) of substrate-free CYP 2B4 measured by cyclic voltammetry are -0.23V and -1.02V (vs. SCE, or 14mV and -776mV vs. NHE) at 21°C. The standard heterogeneous rate constant for electron transfer from the electrode to the heme for the Fe(III/II) couple was estimated at 170s(-1). Experiments indicate that the system is capable of catalytic reduction of dioxygen, however substrate oxidation was not observed. From the variation of E1/2 with temperature (18-40°C), we have measured entropy and enthalpy changes that accompany heme reduction, -151Jmol(-1)K(-1) and -46kJmol(-1), respectfully. The corresponding entropy and enthalpy values are less for the six-coordinate low-spin, imidazole-ligated enzyme (-59Jmol(-1)K(-1) and -18kJmol(-1)), consistent with limited conformational changes upon reduction. These thermodynamic parameters are comparable to those measured for bacterial P450 from Bacillus megaterium (CYP BM3), confirming our prior reports that the surfactant environment exerts a strong influence on the redox properties of the heme., (© 2013.)
- Published
- 2013
- Full Text
- View/download PDF
17. The firing of Dr Lundberg.
- Author
-
Fihn SD and Landefeld S
- Subjects
- American Medical Association, United States, Periodicals as Topic, Publishing
- Published
- 1999
18. Hemorrhagic complications of anticoagulant treatment.
- Author
-
Levine MN, Raskob G, Landefeld S, and Kearon C
- Subjects
- Administration, Oral, Anticoagulants administration & dosage, Dose-Response Relationship, Drug, Heparin administration & dosage, Heparin adverse effects, Humans, Risk Factors, Anticoagulants adverse effects, Hemorrhage chemically induced
- Published
- 1998
- Full Text
- View/download PDF
19. Hemorrhagic complications of anticoagulant treatment.
- Author
-
Levine MN, Raskob G, Landefeld S, and Hirsh J
- Subjects
- Administration, Oral, Anticoagulants administration & dosage, Clinical Trials as Topic, Dose-Response Relationship, Drug, Female, Humans, Male, Risk Factors, Time Factors, Anticoagulants adverse effects, Hemorrhage chemically induced
- Published
- 1995
- Full Text
- View/download PDF
20. Antithrombotic therapy for pulmonary embolism.
- Author
-
Landefeld S
- Subjects
- Animals, Anticoagulants therapeutic use, Fibrinolytic Agents therapeutic use, Humans, Plasminogen Activators therapeutic use, Pulmonary Embolism mortality, Pulmonary Embolism physiopathology, Thromboxanes biosynthesis, Heparin therapeutic use, Pulmonary Embolism drug therapy
- Abstract
These discussions are selected from the weekly staff conferences in the Department of Medicine, University of California, San Francisco. Taken from transcriptions, they are prepared by Drs Homer A. Boushey, Associate Professor of Medicine, and David G. Warnock, Associate Professor of Medicine, under the direction of Dr Lloyd H. Smith, Jr, Professor of Medicine and Chairman of the Department of Medicine. Requests for reprints should be sent to the Department of Medicine, University of California, San Francisco, School of Medicine, San Francisco, CA 94143.
- Published
- 1984
21. Le Bacquet de Mr Mesmer. Paris, circa 1780.
- Author
-
Landefeld S
- Subjects
- History of Medicine, Paris, Engraving and Engravings history, Hypnosis history
- Published
- 1976
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.